摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氟-5-羟基苯甲醛 | 103438-84-2

中文名称
2-氟-5-羟基苯甲醛
中文别名
——
英文名称
2-fluoro-5-hydroxybenzaldehyde
英文别名
——
2-氟-5-羟基苯甲醛化学式
CAS
103438-84-2
化学式
C7H5FO2
mdl
MFCD09038469
分子量
140.114
InChiKey
SNILBNSNKISKLU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    74-75 °C
  • 沸点:
    257.6±20.0 °C(Predicted)
  • 密度:
    1.350±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2913000090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335

SDS

SDS:bc3783f059c3165ca737ac114bbfb572
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Fluoro-5-hydroxybenzaldehyde
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Fluoro-5-hydroxybenzaldehyde
CAS number: 103438-84-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H5FO2
Molecular weight: 140.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质

2-氟-5-羟基苯甲醛在常温常压下为固体,具有微弱的酸性和良好的化学反应活性。它难溶于水,但可溶于常见的有机溶剂如乙酸乙酯和二氯甲烷等。

化学反应

有文献报道,在碱性条件下,2-氟-5-羟基苯甲醛结构中的酚羟基单元可以与苄溴类化合物发生亲核取代反应,从而制备相应的酚醚类衍生物。此外,该物质还可与有机胺类物质缩合生成亚胺类衍生物;其醛基单元在碱性条件下还能与丙酮发生羟醛缩合反应。

应用

2-氟-5-羟基苯甲醛因其特殊的化学性质,在医用化学原料、有机合成中间体及多种功能性化合物的合成中具有广泛的应用。此外,它还用于多取代苯类生物活性分子结构修饰和合成的研究。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    基于氧苄基甘氨酸的PPARα选择性激动剂BMS-711939的发现和临床前评估
    摘要:
    BMS-711939(3)是一种有效的选择性过氧化物酶体增殖物激活受体(PPAR)α激动剂,对人PPARα的EC 50为4 nM,相对于人PPARγ(EC 50 = 4.5μM)和PPARδ的选择性> 1000倍(EC 50 > 100μM)在PPAR-GAL4反式激活检测中。化合物3在临床前研究中还显示出优异的体内功效和安全性,因此被选择用于进一步的临床前评估。描述了临床前动物模型中3的合成,结构-活性关系(SAR)研究和体内药理作用及其ADME谱。
    DOI:
    10.1021/acsmedchemlett.6b00033
  • 作为产物:
    描述:
    4-氟苯酚咪唑四丁基氟化铵叔丁基锂 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 17.5h, 生成 2-氟-5-羟基苯甲醛
    参考文献:
    名称:
    [EN] COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS
    [FR] COMPOSÉS ET COMPOSITIONS POUR LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES CUTANÉS
    摘要:
    提供了一种公式(XXXII)的化合物或药用可接受的盐、溶剂化物、水合物、立体异构体或生理功能衍生物,其中R1、R2、R3、G、A、E、n、p和q在此定义。此外,还提供了包含公式(XXXII)化合物的组合物,以及使用公式(XXXII)化合物的方法,例如,在治疗或预防皮肤病中的应用。
    公开号:
    WO2021154966A1
点击查看最新优质反应信息

文献信息

  • NOVEL CURCUMIN DERIVATIVE
    申请人:Sugimoto Hachiro
    公开号:US20110082295A1
    公开(公告)日:2011-04-07
    To develop a highly safe measure to treat Alzheimer's disease using a secretase-inhibiting substance, there is provided a compound represented by the following general formula (I) or a salt thereof: wherein A represents a phenyl group or the like, R 1 represents a chlorine atom, a bromine atom, or a nitro group or the like, R 2 , R 3 , R 4 , and R 5 each represent a hydrogen atom or the like, and L represents CH 2 —CH 2 or CH═CH.
    为了开发一种高度安全的措施来治疗阿尔茨海默病,提供了一种由以下一般式(I)或其盐表示的化合物: 其中A代表苯基或类似物,R1代表氯原子、溴原子或硝基团等,R2、R3、R4和R5各自代表氢原子或类似物,L代表CH2—CH2或CH═CH。
  • Phosphoric Acid-Catalyzed Asymmetric Synthesis of SPINOL Derivatives
    作者:Shaoyu Li、Ji-Wei Zhang、Xian-Lin Li、Dao-Juan Cheng、Bin Tan
    DOI:10.1021/jacs.6b11435
    日期:2016.12.21
    Axially chiral 1,1'-spirobiindane-7,7'-diol (SPINOL) is the most fundamental and important privileged structure from which other chiral ligands containing a 1,1'-spirobiindane backbone are synthesized. Driven by the development of enantioselective syntheses of axially chiral SPINOL derivatives, we have successfully developed the first phosphoric acid-catalyzed asymmetric approach. This approach is
    轴向手性 1,1'-spirobiindane-7,7'-diol (SPINOL) 是最基本和最重要的特权结构,从中可以合成其他含有 1,1'-spirobiindane 骨架的手性配体。在轴向手性 SPINOL 衍生物的对映选择性合成发展的推动下,我们成功开发了第一个磷酸催化的不对称方法。这种方法具有高度收敛性和官能团耐受性,可有效地以良好的收率和出色的对映选择性提供 SPINOL,从而提供对这种特权结构的实用且直接的访问。应该强调的是,对于制备型合成,催化剂负载量可以降低到仅 0.1 mol%。此外,4,4'
  • Novel piperazine derivatives
    申请人:——
    公开号:US20020143020A1
    公开(公告)日:2002-10-03
    The present invention is a chemical compound of formula (I) 1 or a pharmaceutically acceptable salts, solvates and esters thereof, wherein R 1 to R 4 , A 1 , A 2 m and n are as described in the specification.
    本发明是一种具有公式(I)的化学化合物 1 或其药物可接受的盐、溶剂化物和酯,其中R 1 至R 4 ,A 1 ,A 2 ,m和n如说明书中所述。
  • [EN] HSD17B13 INHIBITORS AND USES THEREOF<br/>[FR] COMPOSÉS ET UTILISATIONS DE CEUX-CI
    申请人:INIPHARM INC
    公开号:WO2021211974A1
    公开(公告)日:2021-10-21
    Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH, or drug induced liver injury (DILI).
    本发明涉及HSD17B13抑制剂及包含所述抑制剂的药物组合物。所述化合物和组合物可用于治疗肝病、代谢性疾病或心血管疾病,例如非酒精性脂肪肝病(NAFLD)或非酒精性脂肪肝炎(NASH),或药物诱导的肝损伤(DILI)。
  • [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2005082890A1
    公开(公告)日:2005-09-09
    Novel inhibitors of Rho-kinases are disclosed.
    新型Rho激酶抑制剂已被披露。
查看更多